MetaCap

AtriCure Earnings

NASDAQ: ATRCHealth CareMedical/Dental InstrumentsUSD

55.81+2.97 (+5.62%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Next earnings date

Wed, Nov 4, 2026

Fiscal period

Sep/2026

EPS estimate

$0.01

AtriCure earnings summary

AtriCure is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $0.01. In its most recent report on Jul 27, 2026 (Q2 2026), ATRC posted EPS of $0.18. Revenue for the quarter was $153.6 million.

Across the last 16 reports, ATRC shares moved an average of 5.6% (in either direction) in the first trading session after results, rising 10 times and falling 6 times.

Summary generated from market data by MetaCap's automated system. Methodology

ATRC earnings history

AtriCure reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Jul 27, 2026—$0.18—+9.6%
May 6, 2026—$0.00—+7.0%
Feb 19, 2026—$0.04—-4.1%
Oct 30, 2025—$-0.01—-7.2%
Jul 30, 2025—$-0.13—+2.6%
Apr 30, 2025—$-0.14—+3.2%
Feb 14, 2025—$-0.33—-6.2%
Oct 30, 2024—$-0.17—+11.8%
Jul 31, 2024—$-0.17—-5.2%
May 2, 2024—$-0.28—+6.7%
Feb 16, 2024—$-0.21—+2.6%
Nov 2, 2023—$-0.20—-5.2%
Jul 26, 2023—$-0.11—+3.4%
May 3, 2023—$-0.14—-0.5%
Feb 22, 2023—$-0.10—+0.3%
Nov 2, 2022—$-0.27—+14.0%

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related